Sionna Therapeutics, Inc. Common Stock (SION)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $150.63M
Last updated: Nov 17, 2026 at 11:05 AM ET
Sionna Therapeutics, Inc. Common Stock (SION) Stock Forecast
Analysts expect Sionna Therapeutics, Inc. Common Stock (SION) to earn -$2.59 per share in the fiscal year ending Dec 31, 2026. Of 12 analysts, 2 rate the stock Buy or Strong Buy, 10 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 2.83, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 17% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 2 | 16.7% |
| Hold | 10 | 83.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 12
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$2.59
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$2.29
- EPS consensus
- Next report
- Mar 1, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$2.59 | -$2.71 to -$2.50 | 7 |
| Dec 31, 2027 | -$2.29 | -$3.18 to -$1.24 | 10 |
Quarterly Estimates
The EPS consensus rises from -$0.58 for the quarter ending Dec 31, 2026 to -$0.51 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.58 | -$0.78 to -$0.33 | 13 |
| Mar 31, 2027 | -$0.51 | -$0.72 to -$0.41 | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 8 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 1 |
| Fiscal year ending Dec 31, 2027 | 3 | 0 |
| Quarter ending Mar 31, 2027 | 3 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.56.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.59 | -$2.45 | -$2.45 | -$2.50 | -$2.56 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.29 | -$2.23 | -$2.23 | -$2.52 | -$2.53 | N/A |
| Quarter ending Mar 31, 2027 | -$0.51 | -$0.44 | -$0.44 | -$0.62 | -$0.62 | N/A |
Frequently Asked Questions About SION
What is the SION stock forecast?
Consensus analyst estimates put Sionna Therapeutics, Inc. Common Stock's EPS at -$2.59 for the fiscal year ending Dec 31, 2026. The consensus rating from 12 analysts is Hold.
How do analysts rate SION stock?
Of 12 analysts covering Sionna Therapeutics, Inc. Common Stock, 0 rate it Strong Buy, 2 Buy, 10 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from SION next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.59, with estimates from -$2.71 to -$2.50 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.29, with estimates from -$3.18 to -$1.24 from 10 analysts.
How many analysts cover SION?
12 analysts rate Sionna Therapeutics, Inc. Common Stock stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SION pages: Overview, Earnings, Forecast, Financials, Competitors